Steven Froelich

420 total citations
10 papers, 122 citations indexed

About

Steven Froelich is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Steven Froelich has authored 10 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 2 papers in Immunology. Recurrent topics in Steven Froelich's work include Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and Genomics and Rare Diseases (2 papers). Steven Froelich is often cited by papers focused on Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (5 papers) and Genomics and Rare Diseases (2 papers). Steven Froelich collaborates with scholars based in United States, United Kingdom and Denmark. Steven Froelich's co-authors include Pin Wang, Kye‐Il Joo, Pin Wang, Arthur Wüster, Wyatt T. Clark, Jonathan H. LeBowitz, Karol Estrada, Marena Trinidad, Xinying Hong and Gouri Yogalingam and has published in prestigious journals such as Nature Communications, PLoS ONE and The American Journal of Human Genetics.

In The Last Decade

Steven Froelich

10 papers receiving 121 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Froelich United States 8 75 53 14 13 11 10 122
Kelly M. Schiabor Barrett United States 7 46 0.6× 27 0.5× 22 1.6× 16 1.2× 5 0.5× 14 126
Kumitaa Theva Das Malaysia 5 114 1.5× 43 0.8× 13 0.9× 11 0.8× 6 0.5× 13 146
Daryl E. Morris United States 5 88 1.2× 27 0.5× 15 1.1× 26 2.0× 17 1.5× 6 165
Tuyen Ong United Kingdom 6 78 1.0× 71 1.3× 22 1.6× 7 0.5× 31 2.8× 11 190
Anssi Nurminen Finland 6 112 1.5× 25 0.5× 38 2.7× 18 1.4× 9 0.8× 9 179
Yu-Ja Huang United States 3 160 2.1× 33 0.6× 24 1.7× 13 1.0× 11 1.0× 4 251
Ewen W. Sommerville United Kingdom 8 207 2.8× 21 0.4× 8 0.6× 16 1.2× 7 0.6× 10 250
Katerina Bendak Australia 7 91 1.2× 33 0.6× 12 0.9× 9 0.7× 9 0.8× 10 153
Jan Ewald Germany 8 79 1.1× 32 0.6× 29 2.1× 21 1.6× 15 1.4× 16 145
Sophie Salomé‐Desnoulez France 7 155 2.1× 26 0.5× 20 1.4× 16 1.2× 11 1.0× 12 209

Countries citing papers authored by Steven Froelich

Since Specialization
Citations

This map shows the geographic impact of Steven Froelich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Froelich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Froelich more than expected).

Fields of papers citing papers by Steven Froelich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Froelich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Froelich. The network helps show where Steven Froelich may publish in the future.

Co-authorship network of co-authors of Steven Froelich

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Froelich. A scholar is included among the top collaborators of Steven Froelich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Froelich. Steven Froelich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Henshaw, Joshua, Kevin Larimore, Andrew C. Melton, et al.. (2025). Targeting a Novel Site in Exon 51 with Antisense Oligonucleotides Induces Enhanced Exon Skipping in a Mouse Model of Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 35(2). 68–80. 1 indexed citations
2.
Trinidad, Marena, Alicia Ljungdahl, Geoffrey Y. Berguig, et al.. (2024). Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants. The American Journal of Human Genetics. 111(6). 1222–1238. 7 indexed citations
3.
Trinidad, Marena, Xinying Hong, Steven Froelich, et al.. (2023). Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix. Genome biology. 24(1). 172–172. 7 indexed citations
4.
Estrada, Karol, Steven Froelich, Arthur Wüster, et al.. (2021). Identifying therapeutic drug targets using bidirectional effect genes. Nature Communications. 12(1). 2224–2224. 18 indexed citations
5.
Choi, Vivian W., Omar L. Francone, David Thomson, et al.. (2016). A7 Drug discovery approach for rare neurological diseases: using novel zinc finger protein technology to develop potential therapy for huntington’s disease. Journal of Neurology Neurosurgery & Psychiatry. 87(Suppl 1). A2.4–A3. 1 indexed citations
6.
Froelich, Steven, et al.. (2011). Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells. Journal of Biological Engineering. 5(1). 1–1. 35 indexed citations
7.
Froelich, Steven, et al.. (2011). Pseudotyping Lentiviral Vectors with Aura Virus Envelope Glycoproteins for DC-SIGN–Mediated Transduction of Dendritic Cells. Human Gene Therapy. 22(10). 1281–1291. 10 indexed citations
8.
9.
Froelich, Steven, et al.. (2010). Lentiviral vectors for immune cells targeting. Immunopharmacology and Immunotoxicology. 32(2). 208–218. 21 indexed citations
10.
Froelich, Steven, et al.. (2009). Targeted gene delivery to CD117‐expressing cells in vivo with lentiviral vectors co‐displaying stem cell factor and a fusogenic molecule. Biotechnology and Bioengineering. 104(1). 206–215. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026